Diabetic nephropathy stem cell therapy - Kidswell Bio
Latest Information Update: 28 Aug 2023
At a glance
- Originator Gene Techno Science
- Developer Kidswell Bio; Minerva Medica; Sapporo Medical University
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetic nephropathies
Most Recent Events
- 28 Aug 2023 No recent reports of development identified for research development in Diabetic-nephropathies in Japan (IV)
- 01 Jul 2021 Gene Techno Science is now called Kidswell Bio
- 18 Jul 2019 Early research in Diabetic nephropathies in Japan (IV) (Gene Techno Science pipeline, July 2019)